# Cancer Prevention and Control Program (05)

> **NIH NIH P30** · RESEARCH INST OF FOX CHASE CAN CTR · 2020 · $42,035

## Abstract

PROJECT SUMMARY/ABSTRACT – CANCER PREVENTION AND CONTROL PROGRAM
The Cancer Prevention and Control (CPC) Program, led by Clapper and Fang, is comprised of 25 Primary
Members and 8 Collaborating Members. Program funding is $9M (project direct costs) annually, including
$7.8M in peer-reviewed funding of which $5M is from the NCI. CPC members have been highly productive and
interactive during the past funding cycle, generating 614 publications, with 16% representing intra-
programmatic and 27% representing inter-programmatic collaborations.
The scientific mission of the CPC Program is to reduce the morbidity and mortality associated with cancer by
focusing on the prevention and control of cancer in defined populations known to be at increased risk for
cancer. The Program has three overarching themes: 1) To identify factors (host, genetic, environmental) that
contribute to cancer risk and/or serve as biomarkers for risk assessment and early detection [Risk
Assessment theme]; 2) To develop and evaluate strategies to enhance risk communication and decision-
making [Risk Communication theme]; and 3) To develop and evaluate strategies to modify risk and enhance
outcomes among at-risk individuals and cancer patients [Risk Modification theme]. Efforts to successfully
realize each of these themes benefit from the activities of multidisciplinary teams working together in a
coordinated fashion to identify and address the complex factors that contribute to and/or influence cancer risk,
risk communication and decision making, and patient and population outcomes. The scientific themes of the
CPC Program are pursued by faculty members who have expertise in diverse fields including molecular
biology, oncology, psychology, medicine, public health, pathology, bioinformatics, health services research,
and epidemiology. These collaborative efforts result in a productive research environment that fosters the
identification of new biomarkers of cancer risk and novel molecular targets for preventive intervention, and the
successful development and implementation of novel, state-of-the-art approaches for reducing cancer risk and
enhancing outcomes in at-risk populations, cancer patients, and their family members. The CPC Program
serves as a primary conduit via which to translate research findings to the surrounding communities, and
efforts across the three themes actively address the cancer burden among minority and other underserved
populations in the catchment area. CPC Program members have successfully accrued 12,246 research
participants to interventional and non-interventional studies during the past 4-year period (2011-2014) and
utilized all 12 of the CCSG-supported Shared Resources.

## Key facts

- **NIH application ID:** 9996589
- **Project number:** 5P30CA006927-55
- **Recipient organization:** RESEARCH INST OF FOX CHASE CAN CTR
- **Principal Investigator:** MARGIE L. CLAPPER
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $42,035
- **Award type:** 5
- **Project period:** 1997-07-01 → 2024-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9996589

## Citation

> US National Institutes of Health, RePORTER application 9996589, Cancer Prevention and Control Program (05) (5P30CA006927-55). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9996589. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*